Skybiotech Healthcare Limited (KAPILCO) is currently trading at 115.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Skybiotech Healthcare Limited (formerly Kapil Cotex Limited) is a listed Indian company originally engaged in spinning, weaving and finishing of textiles that has repositioned itself through an acquisition and a corporate name change to pursue activities in healthcare and life sciences while also earning consultancy, brokerage, capital gains and dividend income. The consolidated financials show a quarter total income of Rs.104.12 lakhs and consolidated revenue from operations of Rs.96.27 lakhs for the quarter ended 31 December 2025, with nine months consolidated total income at Rs.542.03 lakhs and revenue from operations of Rs.526.74 lakhs, indicating the subsidiary contributes meaningful operational scale to group numbers. Corporate actions are prominent: Skybiotech Healthcare Limited changed its name officially on 07 November 2025 and earlier acquired a controlling 72.52% stake in Skybiotech Lifescience Private Limited in 2024, a transaction that is explicitly reported and which the company cites as the primary driver of its changed consolidated reporting structure and business focus. Profitability is strained at the consolidated level: the company reported a consolidated loss before tax of Rs.48.47 lakhs for the quarter and Rs.41.47 lakhs for the nine months ended 31 December 2025, while standalone operations produced minimal or no operating revenue and modest standalone losses, highlighting transitional integration and operational challenges following the strategic shift.

Over the past 52 weeks, Skybiotech Healthcare Limited has traded between a low of ₹113.70 and a high of ₹218.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Skybiotech Healthcare Limited has a market capitalization of approximately 22.02. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Skybiotech Healthcare Limited’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 22.02 Cr, Skybiotech Healthcare Limited is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Skybiotech Healthcare Limited operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Skybiotech Healthcare Limited is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.